Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System
Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 126,185 | $13,553,531 | -5% | 5.8% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.29 | 50 | $4,514.60 | 148,168 | 2024-12-03 | Filing | |
| $41.98 | 25,000 | $1,049,450.00 | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | $357.50 | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | $834.00 | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | $740.08 | 32,294 | 2017-04-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $106.97 | 50,000 | $5,348,315.00 | 178,342 | 2025-07-01 | Filing | |
| $102.88 | 56,372 | $5,799,630.28 | 178,342 | 2025-06-04 | Filing | |
| $103.39 | 89,921 | $9,296,950.17 | 1,476,882 | 2025-06-02 | Filing | |
| $104.05 | 74,522 | $7,754,185.50 | 1,566,803 | 2025-06-02 | Filing | |
| $104.59 | 4,000 | $418,367.60 | 22,479 | 2025-05-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,819,249 | $302,815,535 | 0.34% | |
| 2. | 2,743,100 | $294,471,785 | 1.38% | |
| 3. | 2,671,517 | $286,947,641 | 0.43% | |
| 4. | 580,313 | $62,331,419 | 0.68% | |
| 5. | 414,316 | $44,501,682 | 1.1% |
News See All
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
The healthcare sector has been under pressure, underperforming the S&P 500 over the past several years.
13 Best Large Cap Stocks to Buy Right Now
On Friday, stocks finished lower only one day after the S&P 500 posted a new record high.
Do You Believe in the Growth Trajectory of Boston Scientific Corporation (BSX)?
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
24-Acre Minnetonka Complex Put Up for Sale by Boston Scientific (BSX)
Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to buy.
12 Best Stocks to Invest in for a Month
Momentum investing is a well-established strategy that involves purchasing securities that have demonstrated strong recent performance and selling those that have underperformed.
Was Jim Cramer Right About Boston Scientific Corporation (BSX)?
We recently published a list of 12 Stocks Jim Cramer Was Right About.
12 Stocks Jim Cramer Was Right About
During the latest episode of Mad Money, which aired on Thursday, the 15th of May 2025, Jim Cramer gave some advice on how investors should be approaching the markets from a psychological perspective...
What Makes Boston Scientific Corporation (BSX) A Compelling Name Within The Large-Cap Medical Device Space?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
11 Best Medical Device Stocks to Buy Now
On April 16, CNBC reported that Trump's tariffs are building a divide in the medical community.
Billionaire Hedge Funds
